Finasteride Topical Delivery Systems for Androgenetic Alopecia

被引:21
|
作者
Khan, Muhammad Z. U. [1 ]
Khan, Shujaat A. [1 ]
Ubaid, Muhammad [1 ]
Shah, Aamna [1 ]
Kousar, Rozina [1 ]
Murtaza, Ghulam [1 ]
机构
[1] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan
关键词
Androgenetic alopecia; Finasteride; 5 alpha-reductase isoenzymes; Erectile dysfunction; Topical formulation; Propylene glycol; Flux; LIQUID-CRYSTALLINE NANOPARTICLES; IN-VITRO EVALUATION; PERCUTANEOUS-ABSORPTION; PROPYLENE-GLYCOL; SKIN PENETRATION; RECTAL ABSORPTION; STRATUM-CORNEUM; DRUG-DELIVERY; RAT SKIN; TRANSDERMAL PERMEATION;
D O I
10.2174/1567201815666180124112905
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Androgenetic alopecia, generally recognized as male pattern baldness, is a gradually developing medical and physiological change, which is manifested by continuous hair-loss from scalp. Finasteride (4-aza-3-oxosteroid) is a potent anti-baldness compound that selectively and competitively inhibits the 5 alpha-reductase isoenzymes. Prolonged oral use of finasteride leads to the emergence of sexual disorders including decrease in libido, gynecomastia, erectile dysfunction, ejaculation disorder, orgasm disorders and mood disturbances. Since, hair follicles widely home in 5 alpha-reductase, topical formulations of finasteride in comparison to its oral formulations are expected to potentially reduce its systemic adverse effects. The analysis of literature has revealed some delivery systems developed for the enhanced and localized penetration of finasteride into the skin. These finasteride delivery systems include polymersomes, vesicular nanocarriers, vesicular ethosomal carriers, liposomes and niosomes, liquid crystalline nanoparticles, topical solutions and gels. The aim of this review article is to briefly amass all literature on topical delivery of finasteride to elaborate best dosage form, i.e. formulation having maximum permeation rate. This study will serve as a future perspective regarding topical delivery of finasteride. The literature analysis has exhibited that most of the previous investigators have used propylene glycol in their finasteride-loaded topical formulations, while poloxamer P407, monoolein, transcutol P and choline was used in few formulations. Moreover, among all drug delivery systems, finasteride liposomal gel system consisting of 2% methyl cellulose and gel system containing poloxamer P407 exhibited the highest flux with a value of 28.4 +/- 1.3 mu g/cm(2)h and 23.1 +/- 1.4 mu g/cm(2)h, respectively. Several topical drug delivery techniques such as topical microneedles, aerosol foams, nanoemulsions, microsponges, and emulsifier free formulations, fullerenes, ointments, pastes, creams, gel and lotions are still to be worthy regarding finasteride topical delivery in future.
引用
收藏
页码:1100 / 1111
页数:12
相关论文
共 50 条
  • [41] Minoxidil vs. finasteride in the treatment of men with androgenetic alopecia
    Kumar, B
    Saraswat, A
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 24 - 25
  • [42] Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
    Hu, Ruiming
    Xu, Feng
    Sheng, Youyu
    Qi, Sisi
    Han, Yumei
    Miao, Ying
    Rui, Wenlong
    Yang, Qinping
    [J]. DERMATOLOGIC THERAPY, 2015, 28 (05) : 303 - 308
  • [43] Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia
    Kim, Suyong
    Eum, Jaehong
    Yang, Huisuk
    Jung, Hyungil
    [J]. JOURNAL OF CONTROLLED RELEASE, 2019, 316 : 1 - 11
  • [44] Efficacy of topical caffeine in male androgenetic alopecia
    Dressler, Corinna
    Blumeyer, Anja
    Rosumeck, Stefanie
    Arayesh, Anthony
    Nast, Alexander
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (07): : 734 - 741
  • [45] TOPICAL MINOXIDIL FOR THE THERAPY OF ANDROGENETIC ALOPECIA IN FEMALES
    SHANK, J
    HORDINSKY, M
    LAVILLA, S
    CAPPAS, A
    UNO, H
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A716 - A716
  • [46] Topical cetirizine 1% for treatment of androgenetic alopecia
    Abdelmaksoud, Ayman
    [J]. DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [47] TOPICAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA IN WOMEN
    OLSEN, EA
    [J]. CUTIS, 1991, 48 (03): : 243 - &
  • [48] TOPICAL MINOXIDIL THERAPY IN HEREDITARY ANDROGENETIC ALOPECIA
    DEVILLEZ, RL
    [J]. ARCHIVES OF DERMATOLOGY, 1985, 121 (02) : 197 - 202
  • [50] TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA - REPLY
    KOPERSKI, JA
    ORENBERG, EK
    WILKINSON, DI
    [J]. ARCHIVES OF DERMATOLOGY, 1988, 124 (03) : 322 - 323